Fact CheckerSign in

NCT04757168Completed

Changes in Regional and Global Cardiac Contractility After Stimulation in Scar Zone With the NOGA System

Source: ClinicalTrials.gov · Last updated 1 Jun 2026

Brief summary (registry, in English)

Despite a decrease in voltage amplitude in post-infarction scar areas, greater voltage amplitudes are sometimes observed at the time of local extrasystoles mechanically induced by catheters. However, no study has investigated whether these electrical changes are associated with mechanical changes in local contractility. However, the voltage is closely correlated to the local contractile function as evidenced by the use of the NOGA system.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
4 Feb 2021
Start date
Feb 2022
Primary completion date
Jan 2024
Lead sponsor
University Hospital, Toulouse
NCT number
NCT04757168

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From Feb 2022 to the primary completion date, Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients without ischemic heart disease

Age

  • Women who are pregnant or of childbearing age and without contraception, breastfeeding women

Other

  • Contraindication or non-indication for ventricular tachycardia ablation
  • Patients under guardianship, curatorship or legal protection.

Who the study is looking for

  • \- Patients who should undergo ventricular tachycardia (VT) ablation after a myocardial infarction according to current recommendations, namely: patients with ischemic heart disease (ICD) and with episodes of sustained ventricular tachycardia responsible for internal electric shocks by the implantable automatic defibrillator (ICD) (grade IB recommendation)
  • OR
  • patients with an MIC and an ICD, presenting a first episode of sustained ventricular tachycardia (grade IIa, B recommendation)
  • Affiliated with a social protection scheme
  • Having signed an informed consent

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
ROLLIN Anne
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.